World's Best Scientists 2026 revealed!
Markus Peck-Radosavljevic

Markus Peck-Radosavljevic

D-Index & Metrics

Medicine

D-Index
92
Citations
29390
World Ranking
11362
National Ranking
59

Markus Peck-Radosavljevic publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Markus Peck-Radosavljevic sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 647 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Markus Peck-Radosavljevic D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Markus Peck-Radosavljevic sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 92 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Markus Peck-Radosavljevic is affiliated with the Medical University of Vienna in Austria. Their research focuses primarily on medicine, with a notable concentration in hepatology. Subfields of study include hepatology, epidemiology, oncology, surgery, and pulmonary and respiratory medicine.

Their work addresses several main topics, such as:

  • Liver Disease Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Liver Disease and Transplantation
  • Pancreatic and Hepatic Oncology Research
  • Hepatitis C virus research
  • Pancreatitis Pathology and Treatment
  • Hepatitis B Virus Studies

Markus Peck-Radosavljevic has collaborated frequently with several co-authors, including:

  • Simona Bota
  • M Razpotnik
  • G Essler
  • J Weber-Eibel
  • Florian Hucke

Their publications have appeared in various venues, notably:

  • Zeitschrift für Gastroenterologie
  • Journal für Gastroenterologische und Hepatologische Erkrankungen
  • Endoscopy
  • Journal of Hepatology
  • Liver International

Recent papers by Markus Peck-Radosavljevic include:

  • "NASH limits anti-tumour surveillance in immunotherapy-treated HCC," 2021, Nature
  • "Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial," 2023, The Lancet
  • "Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score," 2021, Journal of Hepatology
  • "Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups," 2020, Gut
  • "Systemic Therapy of Advanced Hepatocellular Carcinoma," 2020, Future Oncology

Best Publications

  • The burden of liver disease in Europe. A review of available epidemiological data.

    Martin Blachier;Henri Leleu;Markus Peck-Radosavljevic;Dominique Charles Valla

  • NASH limits anti-tumour surveillance in immunotherapy-treated HCC

    Dominik Pfister;Dominik Pfister;Nicolás Gonzalo Núñez;Roser Pinyol;Olivier Govaere

  • Effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib: the EVOLVE-1 randomized clinical trial.

    Andrew X. Zhu;Masatoshi Kudo;Eric Assenat;Stéphane Cattan

  • Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial

    Michael Manns;Didier Samuel;Edward J Gane;David Mutimer

  • Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis.

    Simona Bota;Harald Herkner;Ioan Sporea;Petra Salzl

  • Hepatocyte IKKβ/NF-κB Inhibits Tumor Promotion and Progression by Preventing Oxidative Stress-Driven STAT3 Activation

    Guobin He;Guann Yi Yu;Vladislav Temkin;Hisanobu Ogata

  • Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis.

    Mattias Mandorfer;Simona Bota;Philipp Schwabl;Theresa Bucsics

  • Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt

    B Angermayr;M Cejna;F Karnel;M Gschwantler

  • The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma

    Wolfgang Sieghart;Florian Hucke;Matthias Pinter;Ivo Graziadei

  • Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol

    Thomas Reiberger;Gregor Ulbrich;Arnulf Ferlitsch;Berit Anna Payer

  • Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis.

    Thomas Reiberger;Arnulf Ferlitsch;Berit A. Payer;Mattias Mandorfer

  • An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis.

    Angelo Luca;Angelo Luca;Berhard Angermayr;Guido Bertolini;Franz Koenig

  • Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension

    Mattias Mandorfer;Karin Kozbial;Philipp Schwabl;Clarissa Freissmuth

  • Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study.

    Edoardo G Giannini;Atif Zaman;Anna Kreil;Annarosa Floreani

  • Transarterial chemoembolization: modalities, indication, and patient selection

    Wolfgang Sieghart;Florian Hucke;Markus Peck-Radosavljevic

  • Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study

    Lorenza Rimassa;Eric Assenat;Markus Peck-Radosavljevic;Marc Pracht

  • Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma.

    Jens Ricke;Heinz Josef Klümpen;Holger Amthauer;Irene Bargellini

  • Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy.

    Wolfgang Sieghart;Doris Losert;Sabine Strommer;Daniel Cejka

  • Cancer and liver cirrhosis: implications on prognosis and management

    Matthias Pinter;Michael Trauner;Markus Peck-Radosavljevic;Wolfgang Sieghart

  • Report Title: The burden of liver disease in Europe: a review of available epidemiological data

    Martin Blachier;Henri Leleu;Markus Peck-Radosavljevic;Charles Valla

Frequent Co-Authors

Thomas Reiberger
Thomas Reiberger Medical University of Vienna
Michael Trauner
Michael Trauner Medical University of Vienna
Peter Ferenci
Peter Ferenci Medical University of Vienna
Masatoshi Kudo
Masatoshi Kudo Kindai University
Jonel Trebicka
Jonel Trebicka University Hospital of Münster
Christoph Sarrazin
Christoph Sarrazin Goethe University Frankfurt
Fabio Piscaglia
Fabio Piscaglia University of Bologna
Johannes Lammer
Johannes Lammer Medical University of Vienna
Jean-Luc Raoul
Jean-Luc Raoul Institut de Cancérologie de l'Ouest (ICO)
Ulrich Spengler
Ulrich Spengler University of Bonn

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine is a dynamic field, and professionals often pursue related degrees to broaden their expertise or advance their careers. Numerous accredited online programs now offer flexible learning opportunities for students and healthcare professionals. For those interested in preventive medicine and wellness, earning a nutrition bachelor degree online can provide critical knowledge about diet and its impact on health.

Healthcare professionals seeking leadership roles may benefit from cahme-accredited online mha programs, which focus on healthcare administration and management. Registered nurses looking to enhance their qualifications can enroll in online rn to bsn programs without clinical requirements, offering a streamlined path for professional advancement.

Additionally, those aiming for the highest level of nursing practice may consider dnp online programs to achieve a Doctor of Nursing Practice degree. Each of these online pathways can complement or extend a traditional medical education, opening doors to a variety of rewarding roles in healthcare.

Best Scientists Citing Markus Peck-Radosavljevic

Trending Scientists

Recently Published Articles